New shot aims to control stubborn hepatitis b virus
Disease control
Recruiting now
This study is testing an experimental injection called AHB-137 in people who already take standard pills for chronic hepatitis B. The goal is to see if the new treatment can further reduce the amount of virus in the blood and strengthen the body's immune response against it. Abou…
Phase: PHASE2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC